Large-cap Health Care company Elevance Health has logged a -4.1% change today on a trading volume of 1,533,544. The average volume for the stock is 975,237.
Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. Based in Indianapolis, United States the company has 104,900 full time employees and a market cap of $121,185,067,008. Elevance Health currently offers its equity investors a dividend that yields 1.1% per year.
The company is now trading -13.88% away from its average analyst target price of $605.45 per share. The 17 analysts following the stock have set target prices ranging from $558.0 to $665.0, and on average give Elevance Health a rating of buy.
Over the last 52 weeks, ELV stock has risen 18.0%, which amounts to a -8.1% difference compared to the S&P 500. The stock's 52 week high is $550.34 whereas its 52 week low is $412.0 per share. With its net margins declining an average -2.2% over the last 6 years, Elevance Health may not have a strong enough profitability trend to support its stock price.
| Date Reported | Total Revenue ($ k) | Net Profit ($ k) | Net Margins (%) | YoY Growth (%) |
|---|---|---|---|---|
| 2023 | 171,340,000 | 5,987,000 | 3 | -25.0 |
| 2022 | 156,595,000 | 5,894,000 | 4 | 0.0 |
| 2021 | 138,639,000 | 6,158,000 | 4 | 0.0 |
| 2020 | 121,867,000 | 4,572,000 | 4 | -20.0 |
| 2019 | 104,213,000 | 4,807,000 | 5 | 25.0 |
| 2018 | 92,105,000 | 3,750,000 | 4 |
